Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC Culture Supernatant for Mucosal Injury in HSCT
NCT06599346Recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Oct 2020
- Primary completion
- Sep 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of MSC supernatant in mucositis (2 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: Mucosal Injury Healing at 8 weeks. Started Oct 2020; status: recruiting.
02
Drugs
MSC supernatant
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT06599346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06599346.